Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2009

View Archived Issues

Fewer flu-like symptoms seen with CR interferon alfa-2b vs. peginterferon alfa-2b

Piperacillin/tazobactam as prophylactic for febrile complications in prostate needle biopsy

Butylphthalide lessens stroke impact in clinical study

Vertex updates pipeline progress

Periocular delivery of EDL-155 depletes retinoblastoma tumor growth in rats

Endothelin receptor type A antagonist avosentan shows antiglaucoma activity in monkeys

Acucela presents novel isomerase inhibitors for the treatment of AMD

FDA awards fast track designation to Ark's Trinam

PharmaGap ships PhG-alpha-1 cancer drug to NCI for testing

BioCancell reports results from compassionate-use trial of BC-819 in TCC

Merck Serono launches powder formulation of Glucophage in France and U.K.

MorphoSys achieves milestone under HuCAL-derived antibody alliance with Novartis

Pacgen signs letter of intent to acquire Xphase

FDA grants marketing approval to Vanda's Fanapt for schizophrenia

ProStrakan files response to the FDA's action letter regarding the NDA for Fortigel

FDA grants accelerated approval of Avastin for glioblastoma

ChemoCentryx identifies C5aR antagonist CCX-168 as development candidate

Mycophenolate mofetil may be used in patients with chronic inflammatory demyelinating polyneuropathy

Novel antimigraine compounds claimed by Lilly

AstraZeneca describes novel protein kinase B inhibitors for cancer treatment

Novartis claims novel serine protease inhibitors for the treatment of hepatitis C virus

Novel PPAR agonists for the treatment of diabetes discovered by GlaxoSmithKline

FDA grants orphan drug designation to Hyperion's HPN-100 for urea cycle disorders

Genelux reports development of oncolytic virus with antitumor and tumor imaging potential

Monoclonal antibody MBL-HCV1 protects chimpanzees from HCV infection

Novartis receives European approval for Glivec for cancer recurrence following surgery for GIST

FDA approves VeroScience's Cycloset for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...